Market Overview

Benzinga's Top Pre-Market Losers

Related DSW
Top 4 Mid-Cap Stocks In The Apparel Stores Industry With The Lowest PEG Ratio
Footwear Pair Trades From Morgan Stanley; UGG Boots Are A 'Top Holiday Gift'
Good Time to Buy DSW? (Fox Business)
Related INFI
Infinity Announces Clinical And Preclincal Data For Duvelisib To Be Presented at ASH 2014 Annual Meeting
Infinity Reports Topline Data From Phase 2a Exploratory Study Of Duvelisib In Patients With Mild, Allergic Asthma

Body Central (NASDAQ: BODY) shares fell 25.33% to $11.94 in the pre-market trading. Body Central issued downbeat Q2 earnings forecast.

Infinity Pharmaceuticals (NASDAQ: INFI) dipped 22.55% to $10.75 in the pre-market session. Infinity Pharmaceuticals stopped mid-stage trials of saridegib in chondrosarcoma and myelofibrosis

DSW (NYSE: DSW) shares dropped 8.59% to $53.75 in pre-market trading. DSW reiterated its 2012 forecast. The company's board also authorized a new $100 million stock buyback program.

Steel Dynamics (NASDAQ: STLD) dipped 4.90% to $10.48 in the pre-market session. Steel Dynamics issued downbeat Q2 earnings forecast.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (DSW + BODY)

Around the Web, We're Loving...

Get Benzinga's Newsletters